229 related articles for article (PubMed ID: 36103539)
1. Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic β cells.
Szymczak F; Alvelos MI; Marín-Cañas S; Castela Â; Demine S; Colli ML; Op de Beeck A; Thomaidou S; Marselli L; Zaldumbide A; Marchetti P; Eizirik DL
Sci Adv; 2022 Sep; 8(37):eabn5732. PubMed ID: 36103539
[TBL] [Abstract][Full Text] [Related]
2. Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes.
Marroqui L; Dos Santos RS; Op de Beeck A; Coomans de Brachène A; Marselli L; Marchetti P; Eizirik DL
Diabetologia; 2017 Apr; 60(4):656-667. PubMed ID: 28062922
[TBL] [Abstract][Full Text] [Related]
3. IFNɣ but not IFNα increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity.
Thomaidou S; Munoz Garcia A; de Lange S; Gan J; van der Slik AR; Hoeben RC; Roep BO; Carlotti F; Zaldumbide A
Diabetologia; 2023 Nov; 66(11):2075-2086. PubMed ID: 37581620
[TBL] [Abstract][Full Text] [Related]
4. PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction.
Colli ML; Hill JLE; Marroquí L; Chaffey J; Dos Santos RS; Leete P; Coomans de Brachène A; Paula FMM; Op de Beeck A; Castela A; Marselli L; Krogvold L; Dahl-Jorgensen K; Marchetti P; Morgan NG; Richardson SJ; Eizirik DL
EBioMedicine; 2018 Oct; 36():367-375. PubMed ID: 30269996
[TBL] [Abstract][Full Text] [Related]
5. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.
Eizirik DL; Sammeth M; Bouckenooghe T; Bottu G; Sisino G; Igoillo-Esteve M; Ortis F; Santin I; Colli ML; Barthson J; Bouwens L; Hughes L; Gregory L; Lunter G; Marselli L; Marchetti P; McCarthy MI; Cnop M
PLoS Genet; 2012; 8(3):e1002552. PubMed ID: 22412385
[TBL] [Abstract][Full Text] [Related]
6. An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells.
Colli ML; Ramos-Rodríguez M; Nakayasu ES; Alvelos MI; Lopes M; Hill JLE; Turatsinze JV; Coomans de Brachène A; Russell MA; Raurell-Vila H; Castela A; Juan-Mateu J; Webb-Robertson BM; Krogvold L; Dahl-Jorgensen K; Marselli L; Marchetti P; Richardson SJ; Morgan NG; Metz TO; Pasquali L; Eizirik DL
Nat Commun; 2020 May; 11(1):2584. PubMed ID: 32444635
[TBL] [Abstract][Full Text] [Related]
7. Interferon alpha: The key trigger of type 1 diabetes.
Lombardi A; Tsomos E; Hammerstad SS; Tomer Y
J Autoimmun; 2018 Nov; 94():7-15. PubMed ID: 30115527
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress.
Lombardi A; Tomer Y
J Autoimmun; 2017 Jun; 80():48-55. PubMed ID: 28238527
[TBL] [Abstract][Full Text] [Related]
9. Interferon-α promotes MHC I antigen presentation of islet β cells through STAT1-IRF7 pathway in type 1 diabetes.
Jiang H; Li Y; Shen M; Liang Y; Qian Y; Dai H; Xu K; Xu X; Lv H; Zhang J; Yang T; Fu Q
Immunology; 2022 Jun; 166(2):210-221. PubMed ID: 35298836
[TBL] [Abstract][Full Text] [Related]
10. Effect of interferon alpha on MHC class II gene expression in ex vivo human islet tissue.
Harris PE; Malanga D; Liu Z; Hardy MA; Souza F; Del Pozzo G; Winchester RJ; Maffei A
Biochim Biophys Acta; 2006 Jun; 1762(6):627-35. PubMed ID: 16782520
[TBL] [Abstract][Full Text] [Related]
11. IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells.
Coomans de Brachène A; Dos Santos RS; Marroqui L; Colli ML; Marselli L; Mirmira RG; Marchetti P; Eizirik DL
Diabetologia; 2018 Mar; 61(3):636-640. PubMed ID: 29305625
[TBL] [Abstract][Full Text] [Related]
12. Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes.
Richardson SJ; Rodriguez-Calvo T; Gerling IC; Mathews CE; Kaddis JS; Russell MA; Zeissler M; Leete P; Krogvold L; Dahl-Jørgensen K; von Herrath M; Pugliese A; Atkinson MA; Morgan NG
Diabetologia; 2016 Nov; 59(11):2448-2458. PubMed ID: 27506584
[TBL] [Abstract][Full Text] [Related]
13. The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α.
Chandra V; Ibrahim H; Halliez C; Prasad RB; Vecchio F; Dwivedi OP; Kvist J; Balboa D; Saarimäki-Vire J; Montaser H; Barsby T; Lithovius V; Artner I; Gopalakrishnan S; Groop L; Mallone R; Eizirik DL; Otonkoski T
Nat Commun; 2022 Oct; 13(1):6363. PubMed ID: 36289205
[TBL] [Abstract][Full Text] [Related]
14. Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.
Dos Santos RS; Guzman-Llorens D; Perez-Serna AA; Nadal A; Marroqui L
Front Immunol; 2023; 14():1263926. PubMed ID: 37854597
[TBL] [Abstract][Full Text] [Related]
15. Cellular stressors may alter islet hormone cell proportions by moderation of alternative splicing patterns.
Jeffery N; Richardson S; Chambers D; Morgan NG; Harries LW
Hum Mol Genet; 2019 Aug; 28(16):2763-2774. PubMed ID: 31098640
[TBL] [Abstract][Full Text] [Related]
16. Distinct differences in the responses of the human pancreatic β-cell line EndoC-βH1 and human islets to proinflammatory cytokines.
Oleson BJ; McGraw JA; Broniowska KA; Annamalai M; Chen J; Bushkofsky JR; Davis DB; Corbett JA; Mathews CE
Am J Physiol Regul Integr Comp Physiol; 2015 Sep; 309(5):R525-34. PubMed ID: 26084699
[TBL] [Abstract][Full Text] [Related]
17. Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes.
Colli ML; Szymczak F; Eizirik DL
Front Endocrinol (Lausanne); 2020; 11():568446. PubMed ID: 33042023
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes.
Coomans de Brachène A; Castela A; Op de Beeck A; Mirmira RG; Marselli L; Marchetti P; Masse C; Miao W; Leit S; Evans-Molina C; Eizirik DL
Diabetes Obes Metab; 2020 Oct; 22(10):1827-1836. PubMed ID: 32476252
[TBL] [Abstract][Full Text] [Related]
19. Expression of human leukocyte antigen class I in endocrine and exocrine pancreatic tissue at onset of type 1 diabetes.
Skog O; Korsgren S; Wiberg A; Danielsson A; Edwin B; Buanes T; Krogvold L; Korsgren O; Dahl-Jørgensen K
Am J Pathol; 2015 Jan; 185(1):129-38. PubMed ID: 25524212
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death.
Roca-Rivada A; Marín-Cañas S; Colli ML; Vinci C; Sawatani T; Marselli L; Cnop M; Marchetti P; Eizirik DL
Diabetologia; 2023 Aug; 66(8):1544-1556. PubMed ID: 36988639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
